ChenGuang Biotech Group Co., Ltd. (SHE:300138)
China · Delayed Price · Currency is CNY 9.71
-0.07 (-0.72%)
Jun 18, 2026, 3:04 PM CST
ChenGuang Biotech Group Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,691 | 5,995 | 4,213 | 7,155 | 9,446 | 8,897 | |
Market Cap Growth | -11.81% | 42.32% | -41.13% | -24.25% | 6.17% | -3.52% |
Enterprise Value | 7,964 | 7,749 | 5,744 | 8,149 | 10,035 | 9,439 |
Last Close Price | 9.71 | 12.07 | 8.38 | 12.72 | 16.64 | 15.55 |
PE Ratio | 13.17 | 16.25 | 44.79 | 14.92 | 21.76 | 25.31 |
Forward PE | 10.12 | 12.82 | 14.75 | 12.05 | 17.63 | 21.67 |
PS Ratio | 0.72 | 0.91 | 0.60 | 1.04 | 1.50 | 1.83 |
PB Ratio | 1.33 | 1.74 | 1.34 | 2.03 | 2.94 | 3.20 |
P/TBV Ratio | 1.49 | 1.96 | 1.52 | 2.26 | 3.31 | 3.53 |
P/FCF Ratio | - | 77.21 | - | - | 16.91 | - |
P/OCF Ratio | - | 28.16 | - | - | 12.86 | 139.24 |
EV/Sales Ratio | 1.23 | 1.18 | 0.82 | 1.19 | 1.59 | 1.94 |
EV/EBITDA Ratio | 13.39 | 13.03 | 19.75 | 12.87 | 16.91 | 18.52 |
EV/EBIT Ratio | 19.54 | 18.80 | 46.28 | 16.95 | 22.36 | 24.90 |
EV/FCF Ratio | - | 99.80 | - | - | 17.96 | - |
Debt / Equity Ratio | 1.88 | 1.49 | 1.56 | 1.19 | 0.88 | 0.88 |
Debt / EBITDA Ratio | 11.12 | 8.60 | 16.88 | 6.66 | 4.75 | 4.80 |
Debt / FCF Ratio | - | 65.96 | - | - | 5.04 | - |
Net Debt / Equity Ratio | 0.91 | 1.05 | 0.98 | 0.76 | 0.51 | 0.61 |
Net Debt / EBITDA Ratio | 5.42 | 6.05 | 10.62 | 4.26 | 2.77 | 3.35 |
Net Debt / FCF Ratio | -18.21 | 46.35 | -8.29 | -3.47 | 2.94 | -7.87 |
Asset Turnover | 0.61 | 0.71 | 0.80 | 0.89 | 0.98 | 0.92 |
Inventory Turnover | 1.51 | 1.42 | 1.85 | 2.32 | 2.56 | 2.08 |
Quick Ratio | 0.54 | 0.37 | 0.50 | 0.51 | 0.57 | 0.43 |
Current Ratio | 1.24 | 1.29 | 1.48 | 1.61 | 1.79 | 1.48 |
Return on Equity (ROE) | 10.67% | 11.37% | 2.33% | 14.65% | 14.54% | 14.48% |
Return on Assets (ROA) | 2.38% | 2.78% | 0.88% | 3.89% | 4.35% | 4.47% |
Return on Invested Capital (ROIC) | 5.09% | 5.32% | 1.45% | 7.71% | 8.35% | 8.03% |
Return on Capital Employed (ROCE) | 10.70% | 11.10% | 2.80% | 10.50% | 10.80% | 11.60% |
Earnings Yield | 7.59% | 6.15% | 2.23% | 6.71% | 4.59% | 3.95% |
FCF Yield | -3.77% | 1.29% | -8.84% | -10.87% | 5.92% | -2.44% |
Dividend Yield | 3.07% | 2.48% | 1.55% | 1.02% | 0.96% | 0.84% |
Payout Ratio | 47.02% | 43.34% | 185.07% | 37.82% | 33.17% | 31.23% |
Buyback Yield / Dilution | 4.35% | 6.62% | 2.76% | 0.14% | -0.80% | -4.13% |
Total Shareholder Return | 7.38% | 9.11% | 4.31% | 1.16% | 0.16% | -3.29% |